
Prothrombin time (PT) is a blood test which is used to assess the time required to clot a blood. This testÌýis useful to detect and diagnose various bleeding and excessive clotting disorder and also used to monitor the efficacy of various anticoagulant.
Highlights
The global Prothrombin Time Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Prothrombin Time Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prothrombin Time Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Prothrombin Time Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Prothrombin Time Testing include Nihon Kohden, Sekisui Chemical, Universal Biosensors, Roche, Sysmex, Medtronic, Micropoint Biosciences, Danaher and Chrono-log, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prothrombin Time Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Time Testing.
The Prothrombin Time Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prothrombin Time Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Time Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Nihon Kohden
Sekisui Chemical
Universal Biosensors
Roche
Sysmex
Medtronic
Micropoint Biosciences
Danaher
Chrono-log
Thermo Fisher Scientific
Abbott
Helena Laboratories
Siemens
Segment by Type
Mechanical Technology Testing
Electrochemical Technology Testing
Optical Technology Testing
Others
Segment by Application
Hospital
Home Care Setting
Diagnostics Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prothrombin Time Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prothrombin Time Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mechanical Technology Testing
1.2.3 Electrochemical Technology Testing
1.2.4 Optical Technology Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prothrombin Time Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Home Care Setting
1.3.4 Diagnostics Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prothrombin Time Testing Market Perspective (2018-2029)
2.2 Prothrombin Time Testing Growth Trends by Region
2.2.1 Global Prothrombin Time Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prothrombin Time Testing Historic Market Size by Region (2018-2023)
2.2.3 Prothrombin Time Testing Forecasted Market Size by Region (2024-2029)
2.3 Prothrombin Time Testing Market Dynamics
2.3.1 Prothrombin Time Testing Industry Trends
2.3.2 Prothrombin Time Testing Market Drivers
2.3.3 Prothrombin Time Testing Market Challenges
2.3.4 Prothrombin Time Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prothrombin Time Testing Players by Revenue
3.1.1 Global Top Prothrombin Time Testing Players by Revenue (2018-2023)
3.1.2 Global Prothrombin Time Testing Revenue Market Share by Players (2018-2023)
3.2 Global Prothrombin Time Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prothrombin Time Testing Revenue
3.4 Global Prothrombin Time Testing Market Concentration Ratio
3.4.1 Global Prothrombin Time Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prothrombin Time Testing Revenue in 2022
3.5 Prothrombin Time Testing Key Players Head office and Area Served
3.6 Key Players Prothrombin Time Testing Product Solution and Service
3.7 Date of Enter into Prothrombin Time Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prothrombin Time Testing Breakdown Data by Type
4.1 Global Prothrombin Time Testing Historic Market Size by Type (2018-2023)
4.2 Global Prothrombin Time Testing Forecasted Market Size by Type (2024-2029)
5 Prothrombin Time Testing Breakdown Data by Application
5.1 Global Prothrombin Time Testing Historic Market Size by Application (2018-2023)
5.2 Global Prothrombin Time Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prothrombin Time Testing Market Size (2018-2029)
6.2 North America Prothrombin Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prothrombin Time Testing Market Size by Country (2018-2023)
6.4 North America Prothrombin Time Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prothrombin Time Testing Market Size (2018-2029)
7.2 Europe Prothrombin Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prothrombin Time Testing Market Size by Country (2018-2023)
7.4 Europe Prothrombin Time Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prothrombin Time Testing Market Size (2018-2029)
8.2 Asia-Pacific Prothrombin Time Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prothrombin Time Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Prothrombin Time Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prothrombin Time Testing Market Size (2018-2029)
9.2 Latin America Prothrombin Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prothrombin Time Testing Market Size by Country (2018-2023)
9.4 Latin America Prothrombin Time Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prothrombin Time Testing Market Size (2018-2029)
10.2 Middle East & Africa Prothrombin Time Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prothrombin Time Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Prothrombin Time Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nihon Kohden
11.1.1 Nihon Kohden Company Detail
11.1.2 Nihon Kohden Business Overview
11.1.3 Nihon Kohden Prothrombin Time Testing Introduction
11.1.4 Nihon Kohden Revenue in Prothrombin Time Testing Business (2018-2023)
11.1.5 Nihon Kohden Recent Development
11.2 Sekisui Chemical
11.2.1 Sekisui Chemical Company Detail
11.2.2 Sekisui Chemical Business Overview
11.2.3 Sekisui Chemical Prothrombin Time Testing Introduction
11.2.4 Sekisui Chemical Revenue in Prothrombin Time Testing Business (2018-2023)
11.2.5 Sekisui Chemical Recent Development
11.3 Universal Biosensors
11.3.1 Universal Biosensors Company Detail
11.3.2 Universal Biosensors Business Overview
11.3.3 Universal Biosensors Prothrombin Time Testing Introduction
11.3.4 Universal Biosensors Revenue in Prothrombin Time Testing Business (2018-2023)
11.3.5 Universal Biosensors Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Prothrombin Time Testing Introduction
11.4.4 Roche Revenue in Prothrombin Time Testing Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Prothrombin Time Testing Introduction
11.5.4 Sysmex Revenue in Prothrombin Time Testing Business (2018-2023)
11.5.5 Sysmex Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Prothrombin Time Testing Introduction
11.6.4 Medtronic Revenue in Prothrombin Time Testing Business (2018-2023)
11.6.5 Medtronic Recent Development
11.7 Micropoint Biosciences
11.7.1 Micropoint Biosciences Company Detail
11.7.2 Micropoint Biosciences Business Overview
11.7.3 Micropoint Biosciences Prothrombin Time Testing Introduction
11.7.4 Micropoint Biosciences Revenue in Prothrombin Time Testing Business (2018-2023)
11.7.5 Micropoint Biosciences Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Prothrombin Time Testing Introduction
11.8.4 Danaher Revenue in Prothrombin Time Testing Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 Chrono-log
11.9.1 Chrono-log Company Detail
11.9.2 Chrono-log Business Overview
11.9.3 Chrono-log Prothrombin Time Testing Introduction
11.9.4 Chrono-log Revenue in Prothrombin Time Testing Business (2018-2023)
11.9.5 Chrono-log Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Prothrombin Time Testing Introduction
11.10.4 Thermo Fisher Scientific Revenue in Prothrombin Time Testing Business (2018-2023)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Abbott
11.11.1 Abbott Company Detail
11.11.2 Abbott Business Overview
11.11.3 Abbott Prothrombin Time Testing Introduction
11.11.4 Abbott Revenue in Prothrombin Time Testing Business (2018-2023)
11.11.5 Abbott Recent Development
11.12 Helena Laboratories
11.12.1 Helena Laboratories Company Detail
11.12.2 Helena Laboratories Business Overview
11.12.3 Helena Laboratories Prothrombin Time Testing Introduction
11.12.4 Helena Laboratories Revenue in Prothrombin Time Testing Business (2018-2023)
11.12.5 Helena Laboratories Recent Development
11.13 Siemens
11.13.1 Siemens Company Detail
11.13.2 Siemens Business Overview
11.13.3 Siemens Prothrombin Time Testing Introduction
11.13.4 Siemens Revenue in Prothrombin Time Testing Business (2018-2023)
11.13.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Nihon Kohden
Sekisui Chemical
Universal Biosensors
Roche
Sysmex
Medtronic
Micropoint Biosciences
Danaher
Chrono-log
Thermo Fisher Scientific
Abbott
Helena Laboratories
Siemens
Ìý
Ìý
*If Applicable.
